United States HR 1344: Competitive DRUGS Act of 2019

Status: Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law. (as of 2019-03-25)

State: United States · Session: 116 · Bill: HR 1344

Subjects: Administrative remedies, Business expenses, Civil actions and liability, Competition and antitrust, Federal Trade Commission (FTC), Income tax deductions, Intellectual property, Judicial review and appeals, Marketing and advertising, Prescription drugs, Research and development, Tax administration and collection, taxpayers

Sponsors: LLOYD DOGGETT, Alexandria Ocasio-Cortez, Chellie Pingree, EARL BLUMENAUER, ELEANOR HOLMES NORTON, ELIJAH E. CUMMINGS, GRACE F. NAPOLITANO, Gwen Moore, JAMES R. LANGEVIN, John Garamendi, Judy Chu, Katie Hill, Katie Porter, MARCY KAPTUR, MAXINE WATERS, Mark DeSaulnier, Mark Pocan, Matt Cartwright, Peter Welch, ROSA DELAURO, Raul M. Grijalva, Ro Khanna

View United States HR 1344 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.